CHILDERS, MATTHEW LLOYD,DINSMORE, CHRISTOPHER,FULLER, PETER,GUERIN, DAVID,KATZ, JASON DAVID,PU, QINGLIN,SCOTT, MARK E.,THOMPSON, CHRISTOPHER F.,ZHANG, HONGJUN,FALCONE, DANIELLE,TORRES, LUIS,BRUBAKER,
申请号:
EP14767371
公开号:
EP2976340A4
申请日:
2014.03.19
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
Compounds of formula I are provided, which are JAK inhibitors and are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.